The present invention relates to methods for the treatment or prevention of gastric acid disturbances and for reducing the breakdown of acid sensitive agents in the gastrointestinal tract. The present invention also relates to a method for transfecting parietal cells in vivo. The present invention also relates to synthetic oligonucleotides which may be used in these methods.

 
Web www.patentalert.com

< Compositions and methods for inhibiting the synthesis or expression of MMP-1

> Therapeutic agent for nerve damage

> Method for the modulation of function of transcription factors
~ 00503